Finn Sawyer Access to Cancer Testing Act
The summary
What this bill does
Finn Sawyer Access to Cancer Testing Act
This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.
Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.
Legislative timeline
From introduction
Feb 26, 2025
Introduced & referred to committee
Congressional support
Sponsors & Cosponsors
U.S. Representative - CA District 7 · D-CA
13 cosponsors
U.S. Representative - FL District 12 · R-FL
U.S. Representative - CA District 4 · D-CA
U.S. Representative - AZ District 7 · D-AZ
U.S. Representative - NE District 2 · R-NE
Member of Congress · D-FL
Member of Congress · D-OH
U.S. Representative - CT District 4 · D-CT
U.S. Representative - MI District 12 · D-MI
U.S. Representative - AL District 7 · D-AL
U.S. Representative - NC District 1 · D-NC
Member of Congress · D-NJ
Member of Congress · D-NY
+ 1 more cosponsor
Roll-call vote
The vote, by member
The vote, by member
VERSION CHANGES
What changed,
and where.
Loading the bill text comparison.
Bill Metadata
| Congress | 119 |
| Bill Type | HR |
| Bill Number | 1620 |
| Origin Chamber | House |
| Current Status | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| Policy Area | Health |
| Primary Committee | Not assigned |
| Introduced | February 26, 2025 |
| Latest Action | February 26, 2025 |
| Cosponsors | 13 · House vote — · — views |